Moderna, Inc. (MRNA) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Moderna, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:03.972 Standing by, welcome to the Moderna Second Quarter 2026 conference call. 00:00:03.972 -- 00:00:06.733 At this time, all participants are in a listen-only mode. 00:00:06.733 -- 00:00:09.715 After the speaker's presentation, there will be a question and answer session. 00:00:09.715 -- 00:00:13.116 To ask a question during the session, you'll need to press star 1-1 on your telephone. 00:00:13.116 -- 00:00:15.937 You will then hear an automated message advising your hand is raised. 00:00:15.937 -- 00:00:18.738 To withdraw your question, please press star 1-1 again. 00:00:18.738 -- 00:00:21.259 Please be advised, today's conference is being recorded. 00:00:21.259 -- 00:00:23.900 I would now like to hand the conference over to your speaker today, Lavina Talukdar. 00:00:23.900 -- 00:00:25.431 Please go ahead. 00:00:25.431 -- 00:00:30.033 Thank you, Kevin. Good morning, everyone. And thank you for joining us on today's call 00:00:30.033 -- 00:00:35.255 to discuss Moderna's second quarter 2026 financial results and business 00:00:35.255 -- 00:00:40.937 updates. You can access the press release issued this morning as well as the slides 00:00:40.937 -- 00:00:46.159 that we'll be reviewing by going to the investor section of our website. 00:00:46.159 -- 00:00:51.302 On today's call are Stéphane Bancel, our chief executive officer, 00:00:51.302 -- 00:00:56.655 Stephen Hoge, our president, Jamie Mock, our chief Financial Officer, 00:00:56.655 -- 00:01:00.237 and David Berman, our Chief Development Officer. 00:01:00.237 -- 00:01:05.700 Before we begin, please note that this conference call will include forward-looking statements 00:01:05.700 -- 00:01:11.044 made pursuant to the safe harbor provisions of the Private Securities Litigation 00:01:11....